Paper · 62012
Independent differentiative pathways of Ly1 and Ly23 subclasses of T cells. Experimental production of mice deprived of selected T-cell subclasses.
Huber B and 3 others. J Exp Med, 1976. Cited by 121 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Independent differentiative pathways of Ly1 and Ly23 subclasses of T cells. Experimental production of mice deprived of selected T-cell subclasses. Papers, record 62012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/62012
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Independent differentiative pathways of Ly1 and Ly23 subclasses of T cells. Experimental production of mice deprived of selected T-cell subclasses.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Phenotype | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Cytotoxicity Tests, Immunologic | |
| Epitopes | |
| Mice |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References5
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,083,887 | Separation of helper T cells from suppressor T cells expressing different Ly components. I. Polyclonal activation: suppressor and helper activities are inherent properties of distinct T-cell subclasses. | J Exp Med | 1976 | https://conductscience.org/library/papers/1083887 | PubMed |
| 2 | 1,083,888 | Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses. | J Exp Med | 1976 | https://conductscience.org/library/papers/1083888 | PubMed |
| 3 | 4,137,934 | Specific positive selection of lymphocytes reactive to strong histocompatibility antigens. | J Exp Med | 1974 | https://conductscience.org/library/papers/4137934 | PubMed |
| 4 | 1,092,799 | Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity. | J Exp Med | 1975 | https://conductscience.org/library/papers/1092799 | PubMed |
| 5 | 1,092,798 | Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. | J Exp Med | 1975 | https://conductscience.org/library/papers/1092798 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 121 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22,043,824 | Robust immune response elicited by a novel and unique Mycobacterium tuberculosis protein using an optimized DNA/protein heterologous prime/boost protocol. | Immunology | 2012 | https://conductscience.org/library/papers/22043824 | PubMed |
| 7,039,885 | Comparative activity of CP-17,193 and five established immunosuppressives toward the antigens SRBC and EL4. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/7039885 | PubMed |
| 6,976,411 | A specific biosynthetic marker for immature thymic lymphoblasts. Active synthesis of thymus-leukemia antigen restricted to proliferating cells. | J Exp Med | 1982 | https://conductscience.org/library/papers/6976411 | PubMed |
| 6,974,221 | Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes. | J Exp Med | 1981 | https://conductscience.org/library/papers/6974221 | PubMed |
| 6,444,661 | Developmental and communicative interrelations of Ly123 and Ly1 cell sets. | J Exp Med | 1980 | https://conductscience.org/library/papers/6444661 | PubMed |
| 6,156,984 | T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. | J Exp Med | 1980 | https://conductscience.org/library/papers/6156984 | PubMed |
| 3,907,514 | Effects of 3,3',4,4'-tetrachloroazoxybenzene on selected immune parameters of the mouse. | Arch Environ Contam Toxicol | 1985 | https://conductscience.org/library/papers/3907514 | PubMed |
| 3,533,258 | The Lyt phenotype of the T cells responsible for in vivo tumor rejection in syngeneic mice. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3533258 | PubMed |
| 719,951 | Induction of a stable hapten-specific immunosuppression by a hapten conjugated to poly(N-vinylpyrrolidone) (PVP). | Clin Exp Immunol | 1978 | https://conductscience.org/library/papers/719951 | PubMed |
| 342,812 | [Recent perspectives on the mechanisms of rejection in kidney transplantation (author's transl)]. | Klin Wochenschr | 1978 | https://conductscience.org/library/papers/342812 | PubMed |
1 to 10 of 26
See all 26 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/62012
GET https://conductscience.org/api/papers/v1/62012/cited_by?page=2